Key result
Sumatriptan use was associated with myocardial infarction in a 50-year-old woman with migraine headaches, highlighting the need to consider cardiac risk factors before initiating therapy.
Case Report (n=1)
Sumatriptan use can be associated with myocardial infarction, highlighting the need to assess cardiac risk factors before initiating therapy in migraine patients.
Vascular headaches are a relatively common phenomenon. Increasing numbers of patients with headache are being considered for treatment with the selective serotonin-receptor agonist sumatriptan succinate because of its potential for pronounced therapeutic efficacy in selected patients. Sumatriptan-associated myocardial infarction occurred in a 50-year-old woman with a history of migraine headaches. Cardiac risk factors that must be considered in all patients with migraine before initiation of therapy include concomitant ergotamine use, postmenopausal state, male gender older than 40 years, family history of heart disease, cigarette smoking, hypertension, diabetes mellitus, as reviewed in this report.
No takes yet. Share an insight, caveat, or question.
A 1997 study conducted a case report in Migraine headaches (n=1). Sumatriptan succinate was evaluated on Myocardial infarction. Sumatriptan use was associated with myocardial infarction in a 50-year-old woman with migraine headaches, highlighting the need to consider cardiac risk factors before initiating therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: